FDA Permits Advertising of Vuse Tobacco-Flavored Vapes

Medically reviewed by Carmen Pope, BPharm. Final up to date on July 19, 2024.

By Robin Foster HealthDay Reporter

FRIDAY, July 19, 2024 — The U.S. Meals and Drug Administration on Thursday licensed the sale of the nation’s best-selling e-cigarette.

The company’s determination solely applies to a number of tobacco-flavored variations of the reusable product, offered as Vuse. In January 2023, the FDA rejected R.J. Reynold’s utility for its extra well-liked menthol taste, however the firm has challenged that ruling in courtroom.

Final month, the FDA granted competitor Njoy the first authorization for a menthol-flavored e-cigarette. That vaping model is managed by tobacco large Altria.

Regardless of the Vuse authorization, the FDA careworn that e-cigarettes are removed from protected.

“All tobacco merchandise are dangerous and doubtlessly addictive,” the company stated in a brand new launch asserting the choice. “Those that don’t use tobacco merchandise, particularly younger individuals, shouldn’t begin.”

In its determination, the company famous that tobacco-flavored e-cigarettes don’t maintain the identical attraction amongst youth that fruit- and candy-flavored vaping merchandise do.

“Whereas FDA stays involved concerning the danger of youth use of all e-cigarettes, youth are much less doubtless to make use of tobacco‐flavored e-cigarette merchandise in comparison with different flavors,” the company stated. “In response to the , Vuse was among the many mostly reported manufacturers utilized by center and highschool college students at the moment utilizing e-cigarette. Nevertheless, solely 6.4% of scholars who at the moment used e-cigarettes reported utilizing tobacco‐flavored merchandise.”

To additional discourage vaping amongst teenagers and adolescents, the FDA added that it has positioned robust advertising and marketing restrictions on the Vuse merchandise, to protect in opposition to youth entry and publicity.

Previously 12 months, Vuse made up 40% of U.S. vaping gross sales, the Related Press reported. Most gross sales are for Vuse menthol merchandise, which stay obtainable underneath a courtroom order whereas Reynolds challenges the FDA’s menthol ruling.

Juul Labs now trails Vuse within the vaping market, accounting for lower than 1 / 4 of retail gross sales, the AP reported. The corporate needed to slash its advertising and marketing and promotions following authorized settlements with states, native governments and households that blamed the model’s glossy e-cigarettes for hooking youngsters on nicotine.

Some manufacturers like Vuse have been offered in america for years, awaiting FDA motion on their scientific functions, the AP reported. The market additionally consists of 1000’s of fruit- and candy-flavored merchandise from China which might be unlawful however nonetheless offered in comfort shops and vape retailers.

The FDA missed a self-imposed courtroom deadline final month to wrap up its yearslong overview of main vaping manufacturers. Juul’s merchandise stay underneath federal overview, though FDA lately rescinded a 2022 order that will have pressured the merchandise off the market. That order by no means took impact as a result of FDA regulators initially agreed to put it on maintain following a authorized problem by Juul.

Greater than 26 million functions for vaping merchandise have been rejected by the FDA, with solely a handful of merchandise licensed to assist people who smoke to this point.

Disclaimer: Statistical information in medical articles present normal tendencies and don’t pertain to people. Particular person elements can differ vastly. At all times search customized medical recommendation for particular person healthcare selections.

© 2024 HealthDay. All rights reserved.

Posted July 2024

Extra information sources

Subscribe to our e-newsletter

No matter your subject of curiosity, subscribe to our newsletters to get the most effective of Medicine.com in your inbox.